BioMarin Pharmaceutical | BMRN - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Bayer EUR 7.08B 700M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Gilead Sciences USD 808M 226M 2025-09
Incyte USD 1.63B 1.46B 2025-12
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 2.89B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12